Clinical Trial Update: Platelet Aggregation Inhibition in Children on Clopidogrel (PICOLO) [Phase 2]

View source ↗

Summary

The Phase 2 trial PICOLO evaluating platelet aggregation inhibition in children taking clopidogrel has completed. The study, sponsored by Sanofi, involved parti…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Blood Platelet Disorders
• Congenital Heart Defects

Drugs mentioned

• CLOPIDOGREL (CLOPIDOGREL)

Snippet

Sponsor: Sanofi | Conditions: Congenital Heart Defects, Blood Platelet Disorders | Phase 2 | Status: COMPLETED